Karuna Therapeutics, Inc. (KRTX): Price and Financial Metrics
KRTX Price/Volume Stats
| Current price | $329.83 | 52-week high | $329.99 |
| Prev. close | $329.74 | 52-week low | $158.38 |
| Day low | $329.75 | Volume | 1,868,500 |
| Day high | $329.99 | Avg. volume | 832,048 |
| 50-day MA | $317.38 | Dividend yield | N/A |
| 200-day MA | $228.31 | Market Cap | 12.58B |
KRTX Stock Price Chart Interactive Chart >
Karuna Therapeutics, Inc. (KRTX) Company Bio
Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company develops treatments for people afflicted with schizophrenia. Karuna Therapeutics was founded in July 2009 by Andrew Miller, Eric Elenko and Peter Jeffrey Conn and is headquartered in Boston, MA.
KRTX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | 75.35% |
| 3-year | 152.76% |
| 5-year | 287.99% |
| YTD | 4.21% |
| 2023 | 61.07% |
| 2022 | 50.00% |
| 2021 | 28.95% |
| 2020 | 34.84% |
| 2019 | N/A |
Loading social stream, please wait...